TRX4 Monoclonal Antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TRX4 Monoclonal Antibody, covering 2017-11-13 to 2017-11-13. Get the full timeline:
Most recent: Clinical Trial Update: TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM) [Phase 2]